{
  "docId": "019dd923-5f69-752d-a9b6-2758ff8024b8",
  "docSlug": "IOYPUci1JeH6qtF9hngI",
  "documentTitle": "See the 21-slide pitch deck a biotech startup used to convince investors like Pfizer to bet on fixing damaged organs",
  "authorId": "Pitchdecks",
  "authorName": "Agomab Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 10,
  "pageCount": 21,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "pain_points",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "Includes a medical illustration of a stricture with diagnostic criteria (wall thickness, luminal diameter).",
  "elementsJson": [
    "action_title",
    "bullet_list",
    "photo"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5f69-752d-a9b6-2758ff8024b8/10",
  "deckHref": "/decks/019dd923-5f69-752d-a9b6-2758ff8024b8",
  "deckJsonHref": "/decks/019dd923-5f69-752d-a9b6-2758ff8024b8.json",
  "deckAnchorHref": "/decks/019dd923-5f69-752d-a9b6-2758ff8024b8#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.67,
        "y": 0.5
      },
      "kind": "image",
      "text": "Medical illustration of intestinal stricture with diagnostic measurements",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e5a65c7-1480-4ff2-99dc-e3634a331d0f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.85,
        "x": 0.04,
        "y": 0.22
      },
      "kind": "list",
      "text": "50% of all CD patients develop clinically apparent fibrostenotic strictures\nAs a result, 40-70% needs surgery within 10 years after diagnosis due to strictures\nPost-operative recurrence is common and recurrence by the third postoperative year is 85%-100%\nCurrent therapies have no impact on stricture incidence and severity\nHigh unmet need has led to increased industry and KOL interest, but competition is still limited",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "13f3752b-4bea-4f37-91a9-b3bc29fb6b0c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "surgery rate: 85%-100%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-9d6a-7169-ab36-ad3d79c97047",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.12,
        "y": 0.07
      },
      "kind": "title",
      "text": "High unmet need in fibrostenotic Crohn’s Disease",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "83418fa0-6760-4a4a-8ab9-b40a2dd5bd77",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 10,
      "beatId": "0b42f45b-e0e2-431b-8d05-54abb1d12396",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "High unmet need in fibrostenotic Crohn’s Disease",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 10,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "13a4ad43-cc52-4abf-9be2-86cd555b2bce",
      "evidence": "High unmet need in fibrostenotic Crohn’s Disease",
      "position": 0,
      "objective": "What is the cost of not treating fibrostenotic Crohn’s Disease?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}